A Prospective, Comparative, Clinical Study to Evaluate the Safety and Efficacy of Two Different 0.1% Riboflavin Solutions Used in Collagen Crosslinking Treatment for Patients with Keratoconus.
Sheetal BrarSri GaneshShilpa S ReddyNagesh BnDhwni ShahanandPublished in: Clinical ophthalmology (Auckland, N.Z.) (2021)
Ctri/2019/11/021841 (Www.ctri.nic.in).